Organ-on-a-Chip Market Size
Organ-on-a-Chip Market to surpass USD 1271.6 million by 2031 from USD 68.3 million in 2021 at a CAGR of 38.50% in the forecasted period.
Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates the activities, mechanics, and physiological responses of the organ system. It is the size of a AA battery that allows seeing the functionality of organs, their behavior, and response at the molecular and cellular levels.
Market Highlights
Organ-on-a-Chip Market is expected to project a CAGR of 38.50% during the forecast period, 2021-2031
An increase in animal testing, research funding, capital investments, new product launches, and a rise in technological investments is likely to increase the growth of the market.
Global Organ-on-Chips Market: Segments
By organ type
it can be categorized into the liver, heart, lungs, and others. The liver segment shows significant growth due to the increased liver-related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.
By application
it can be segmented into drug discovery, toxicology research, and other applications. Technological advancements and an increase in drug toxicity demand are reasons for the growth of the drug segment.
Market Dynamics
Drivers
High usage is expected to increase the market size
The growing usage of the organ-on-chips market for animal testing and in the healthcare sector and a rising number of alliances between the pharmaceutical firms and chips manufacturers are expected to increase the market growth. Additionally, technological advancements and an increase in drug toxicity demand is also a driver in the market.
Restraint
Technical issues and high costs will restrain the market growth
There are a lot of technical problems linked with organ-on-chip technology which acts as a restraint in the market along with the high cost as well as complexities in the organ-on-chip model. Restrictions in polydimethylsiloxane which is the most commonly used material for fabrications of the organ-on-chips market also act as a hindrance to the growth of the market.
Global Organ-on-Chips Market: Regions
North America holds the largest share in the organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world-class research institutes and pharmaceutical and biotechnology industries in the region. Though, the APAC region is expected to become the fastest-growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.
Global Organ-on-a-Chip Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities-o-Y Growth, CAGR – the United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and the Rest of APAC
- MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Global Organ-on-Chips Market: Key players
- Nortis
Business Strategy, Key Product offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
- Organovo Holdings, Inc.
- Hurel Corporation
- Insphero AG
- MIMETAS BV
- Mimetas
- Emulate
- InSphero
- Ascendance Bio
- AxoSim
The global Organ-on-a-Chip Market report also contains an analysis on:
Global Organ-on-Chips Market segments
- By type
- Liver
- Lungs
- Heart
- others
- By application
- drug discovery
- toxicology research
- other applications
- By end-user
- Pharmaceutical and biotechnology companies
- academic and research institutes
- others
- Global Organ-on-Chips Market dynamics
- Global Organ-on-Chips Market size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
Frequently Asked Questions (FAQ):
The Organ-on-a-Chip Market size was estimated at USD 68.3 million in 2021 and is expected to reach USD 1271.6 million by 2030.
Nortis, Organovo Holdings, Inc., Hurel Corporation, Insphero AG, MIMETAS BV, Mimetas, Emulate, InSphero, Ascendance Bio, AxoSim
By organ type and By application segment are anticipated to hold the largest Food Service Equipment Market
Drivers: High usage is expected to increase the market size
Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates the activities, mechanics, and physiological responses of the organ system.
_Market.jpg)
.png){kind=icon}
